People · Operator

Alexander S. Tokman

Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology

1
Companies
1
Filings
$26.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
ENDRA Life Sciences Inc.BiotechnologySeries A$26.8M$40.9M2019
Operator network

Alexander S. Tokman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

ALEXANDER TOKMAN · 4 companies · 1 sharedALEXANDER TOKMANRichard Jacroux · 4 companies · 1 sharedRichard JacrouxDavid R. Wells · 3 companies · 1 sharedDavid R. WellsLouis J. Basenese · 2 companies · 1 sharedLouis J. BaseneseMichael Thornton · 2 companies · 1 sharedMichael ThorntonAlexander Y. Tokman · 1 companies · 1 sharedAlexander Y. Tokm…Anthony J. DiGiandomenico · 1 companies · 1 sharedAnthony J. DiGian…Anthony R. DiGiandomenico · 1 companies · 1 sharedAnthony R. DiGian…Francois R. Michelon · 1 companies · 1 sharedFrancois R. Miche…Michael J. Harsh · 1 companies · 1 sharedMichael J. HarshMichael R. Thornton · 1 companies · 1 sharedMichael R. Thornt…Michael S. Harsh · 1 companies · 1 sharedMichael S. HarshSanjiv S. Gambhir · 1 companies · 1 sharedSanjiv S. GambhirENDRA Life Sciences Inc. · $26.8M raisedENDRA Life Sciences I…Alexander S. TokmanAT
Alexander S. Tokman Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Alexander S. Tokman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
ALEXANDER TOKMAN14
Richard Jacroux14
David R. Wells13
Louis J. Basenese12
Michael Thornton12
Sanjiv S. Gambhir11
Michael R. Thornton11
Francois R. Michelon11
Alexander Y. Tokman11
Anthony J. DiGiandomenico11
Michael J. Harsh11
Michael S. Harsh11
Anthony R. DiGiandomenico11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.